Results 271 to 280 of about 63,621 (308)

Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?

open access: yes
British Journal of Clinical Pharmacology, EarlyView.
Christina Gao   +3 more
wiley   +1 more source

Evaluating effectiveness of risk minimization through healthcare professional surveys: A review of post‐authorization studies, 2022–2024

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Risk minimization measures (RMMs) are key regulatory tools to ensure safe medicinal product use. Regulatory guidelines recommend pre‐specifying the targets, or ‘thresholds’, for assessing RMM effectiveness. We aimed to review recent industry‐sponsored post‐authorization safety studies (PASS) that evaluated the effectiveness of RMMs ...
Kexin Zhu   +7 more
wiley   +1 more source

Reception Baseline Assessment and ‘small acts’ of micro‐resistance

open access: yesBritish Educational Research Journal, EarlyView.
Abstract In September 2021, following the global COVID‐19 pandemic, the Department for Education introduced a national standardised digital Reception Baseline Assessment (RBA) for all English 4‐year‐old children. We analyse RBA and its associated Quality Monitoring Visits, as a further intensification of the new public management of early years ...
Guy Roberts‐Holmes   +2 more
wiley   +1 more source

FDA-Cleared Artificial Intelligence Medical Devices in Orthopaedic Surgery. [PDF]

open access: yesJ Am Acad Orthop Surg Glob Res Rev
Lee B   +5 more
europepmc   +1 more source

Entrepreneurship beyond the lab: commercializing your creative outputs. [PDF]

open access: yesBMC Proc
Martínez-Montemayor MM   +2 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy